FDA approves Biogen's $56,000 drug for Alzheimer's

FDA approves Biogen's $56,000 drug for Alzheimer's

By Anna Domanska - Jun 09, 2021

The Food and Drug Administration of the US approved on Monday Biogen Inc’s Aducanumab to treat Alzheimer’s disease amidst the controversy of its efficacy. Biogen has pr

Read More
Biogen, Denali to partner for development of Parkinson's disease Med

Biogen, Denali to partner for development of Parkinson's disease Med

By Anna Domanska - Aug 07, 2020

The partnership is bound to attract a lot of attention as Parkinson’s, a debilitating degenerative neuro disease has no known cure. A medicinal program will push both compani

Read More
Biogen Pays $124 Million to Develop Gene-Based Therapies

Biogen Pays $124 Million to Develop Gene-Based Therapies

By Carrie Ann - Jul 03, 2015

On Thursday, Biogen Inc. will enter into the area of eye-disease treatment by paying Applied Genetic Technologies Corp. (AGTC) about $124 million for licensing its products, and co

Read More